Prevalence of sarcopenia in esophageal cancer patients receiving preoperative neoadjuvant therapy: a systematic review and meta-analysis

Key Points

• Sarcopenia was observed in esophageal cancer patients undergoing neoadjuvant therapy, impacting their health outcomes significantly.
• The meta-analysis revealed a prevalence rate of 40% among patients treated with neoadjuvant therapy for esophageal cancer.
• This systematic review evaluated multiple studies to assess the relationship between sarcopenia and neoadjuvant treatment outcomes.
• Highlighting the importance of screening for sarcopenia, as timely intervention may improve patient care and outcomes.